Mécanisme < Mécanisme action < Médecine

Facettes :

List of bibliographic references indexed by Mécanisme action

Number of relevant bibliographic references: 35.
[20-40] [0 - 20][0 - 35]

Ident.	Authors (with country if any)	Title
003B63 (1997)	Chien-Tsai Lai [Canada] ; Peter H. Yu [Canada]	R(−)-Deprenyl Potentiates Dopamine-Induced Cytotoxicity toward Catecholaminergic Neuroblastoma SH-SY5Y Cells
003C23 (1997)		Pallidotomie
003E90 (1996)	W. G. Tatton [Canada] ; R. M. E. Chalmers-Redman [Canada]	Modulation of gene expression rather than monoamine oxidase inhibition : (-)-Deprenyl-related compounds in controlling neurodegeneration
003E95 (1996)	D. Boismenu [Canada] ; O. Mamer [Canada] ; L. Ste-Marie [Canada] ; L. Vachon [Canada] ; J. Montgomery [Canada]	In vivo hydroxylation of the neurotoxin, 1-methyl-4-phenylpyridinium, and the effect of monoamine oxidase inhibitors : Electrospray-MS analysis of intra-striatal microdialysates
003F76 (1995)	Céline Gagnon [Canada] ; Baltazar Gomez-Mancilla [Canada] ; Rudolf Markstein [Suisse] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]	Effect of adding the D-1 agonist CY 208–243 to chronic bromocriptine treatment of MPTP-monkeys: Regional changes of brain dopamine receptors
004030 (1995)	Pj Blanchet [Canada] ; B. Gomez-Mancilla [Canada] ; T. Di Paolo [Canada] ; Pj Bédard [Canada]	Is striatal dopaminergic receptor imbalance responsible for levodopa‐induced dyskinesia?
004083 (1995)	J.-A. St-Pierre [Canada] ; P. J. Bedard	Systemic administration of the NMDA receptor antagonist MK-801 potentiates circling induced by intrastriatal microinjection of dopamine
004201 (1994)	E. Scarr [Canada] ; D. M. Wingerchuk [Canada] ; A. V. Juorio [Canada] ; I. A. Paterson [Canada]	The effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesions
004454 (1993)	P. Blanchet [Canada] ; P. J. Bedard [Canada] ; D. R. Britton ; J. W. Kebabian	Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys
004463 (1993)	J. Poirier [Canada] ; C. Thiffault	Are free radicals involved in the pathogenesis of idiopathic Parkinson's disease ?
004815 (1991)	W. G. Tatton [Canada] ; C. E. Greenwood	Rescue of dying neurons : a new action for deprenyl in MPTP parkinsonism
004827 (1991)	B. Gomez-Mancilla [Canada] ; P. J. Bedard	Effect of D1 and D2 agonists and antagonists on dyskinesia produced by L-DOPA in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys
004A59 (1989)	G. S. Robertson [Canada] ; D. G. Herrera [Canada] ; M. Dragunow [Canada] ; H. A. Robertson [Canada]	L-DOPA activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra
004C63 (1988)	R. J. Riopelle	Adrenal medulla autografts in Parkinson's disease: a proposed mechanism of action
004D90 (1987)	H. A. Robertson ; G. S. Robertson	Hypothesis. Combined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Mécanisme action" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Mécanisme action" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Mécanisme action
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022